BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
19 results:

  • 1. The immune response-related genomic alterations in patients with malignant melanoma.
    Li L; Xiang T; Li X
    Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
    Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D
    Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of lrp1b in Glioblastoma.
    Peixoto J; Príncipe C; Pestana A; Osório H; Pinto MT; Prazeres H; Soares P; Lima RT
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511044
    [No Abstract]    [Full Text] [Related]  

  • 4. Chromosomal Aberrations Accumulate during Metastasis of Virus-Negative Merkel cell Carcinoma.
    Robb TJ; Ward Z; Houseman P; Woodhouse B; Patel R; Fitzgerald S; Tsai P; Lawrence B; Parker K; Print CG; Blenkiron C
    J Invest Dermatol; 2023 Jul; 143(7):1168-1177.e2. PubMed ID: 36736454
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MN1 altered astroblastoma with APC and lrp1b gene mutations: a unique variant in the cervical spine of a pediatric patient.
    Mugge L; Dang DD; Stabingas K; Keating G; Rossi C; Keating R
    Childs Nerv Syst; 2023 May; 39(5):1309-1315. PubMed ID: 36648513
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.
    Dong Y; Zhao L; Duan J; Bai H; Chen D; Li S; Yu Y; Xiao M; Zhang Q; Duan Q; Sun T; Qi C; Wang J; Wang Z
    Cell Prolif; 2022 Sep; 55(9):e13283. PubMed ID: 35811392
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
    Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M
    Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
    Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
    Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.
    Luo L; Lin L; Zhang X; Cai Q; Zhao H; Xu C; Cong Q
    Biomed Res Int; 2020; 2020():1314967. PubMed ID: 31998776
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
    Rahane CS; Kutzner A; Heese K
    J Neurooncol; 2019 Jan; 141(1):57-70. PubMed ID: 30414097
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3.
    Konukiewitz B; Jesinghaus M; Steiger K; Schlitter AM; Kasajima A; Sipos B; Zamboni G; Weichert W; Pfarr N; Klöppel G
    Hum Pathol; 2018 Jul; 77():70-79. PubMed ID: 29596894
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
    Leonard MK; McCorkle JR; Snyder DE; Novak M; Zhang Q; Shetty AC; Mahurkar AA; Kaetzel DM
    Lab Invest; 2018 Mar; 98(3):327-338. PubMed ID: 29058705
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. lrp1b deletion is associated with poor outcome for glioblastoma patients.
    Tabouret E; Labussière M; Alentorn A; Schmitt Y; Marie Y; Sanson M
    J Neurol Sci; 2015 Nov; 358(1-2):440-3. PubMed ID: 26428308
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
    Nikolaev SI; Rimoldi D; Iseli C; Valsesia A; Robyr D; Gehrig C; Harshman K; Guipponi M; Bukach O; Zoete V; Michielin O; Muehlethaler K; Speiser D; Beckmann JS; Xenarios I; Halazonetis TD; Jongeneel CV; Stevenson BJ; Antonarakis SE
    Nat Genet; 2011 Dec; 44(2):133-9. PubMed ID: 22197931
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.
    Annabi B; Doumit J; Plouffe K; Laflamme C; Lord-Dufour S; Béliveau R
    Mol Carcinog; 2010 Jul; 49(7):710-7. PubMed ID: 20564348
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. gamma-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells.
    Liu CX; Ranganathan S; Robinson S; Strickland DK
    J Biol Chem; 2007 Mar; 282(10):7504-11. PubMed ID: 17227771
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.